A recent Scottish Ophthalmic Surveillance Unit survey reported a low incidence of persistent Cystoid Macular Oedema (pCMO) at 3 months following uncomplicated cataract surgery in Scotland (2.2 cases per 10,000; 0.02%; based on an average of 42,000 cataract operations/year), with inconsistent and variable management regimes [1]. As there are over 400,000 cataract procedures performed annually across the UK, that could translate to more than 80 pCMO cases nationally. To provide a national view regarding pCMO management, we surveyed the 186 consultant members of UK & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) to identify their recommendations in November 2020.

41 responses were received within 6 weeks (response rate 22%; 73.2% from England, 14.6% Scotland). 53.7% worked in both public and private practice (34.1% NHS only). Respondents reported high levels of experience (70.7% consultant for >10 years) and regular surgical exposure (46.3% <10 cataract operations/week; 39.0% 10–19; 14.6% 20+).

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD